St. Joseph’s PHX first provider of new brain cancer test

June 25, 2009

By hammersmith

[Source: St. Joseph’s] – St. Joseph’s Hospital and Medical Center in Phoenix has partnered with Castle Biosciences, Inc. to provide the nation’s first genomics-based test for patients suffering from glioblastoma multiforme, the most deadly form of primary brain cancer  This new test is used to help doctors and patients consider various treatment options.

Castle Biosciences chose St. Joseph’s DNA Diagnostics Lab as the sole location to perform this test following an extensive review process.  The Greater Phoenix Economic Council facilitated key connections that led to the agreement between St. Joseph’s and Castle Biosciences.  Physicians from across the United States have now begun sending cases to Castle for DecisionDx-GBM testing to be run in St. Joseph’s DNA Diagnostics Lab.

For more information click here.